Digital Pathology Global Market to 2030: Increasing Adoption of Telepathology Drives Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Digital Pathology Market Size, Share & Trends Analysis Report By Application (Academic Research, Disease Diagnosis), By Product (Software, Device), By End-use (Diagnostic Labs, Hospitals), And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

The global digital pathology market size is expected to reach USD 1.73 billion by 2030, registering a CAGR of 7.7%.

The market is anticipated to witness exponential growth owing to the rising prevalence of chronic diseases aided by increasing demand for accurate diagnostics. Chronic diseases affect around one in every three adults. Whereas, according to the CDC, in the U. S., approximately, 51.8% of adults have at least one chronic disease.

Digital pathology, including molecular tissue profiling, biobanking, tissue microarray analysis, and molecular biology, plays an important role in the drug development pipeline and companion diagnostics. The growing demand for high-quality tissue samples in tissue-based biomarker research is expected to drive technology adoption over the forecast period.

The increasing adoption of telepathology with the launch of newer versions of the technology, such as in June 2022, Tribun Health launched TeleSlide Patho 5, an online telepathology platform used for providing clinical and timely expertise to patients. Moreover, the market is expected to see intense competition in the near future as companies adopt more stringent strategies to compete.

Moreover, technological advancements, such as the digitization of pathology lab makes the specialty more efficient, the specimen more reproducible, and pathologists' work easier. In the past few years, several breakthrough advancements have provided a significant boost to the market.

For instance, in September 2021, Paige received FDA approval for Paige Prostate, an AI solution for the detection of prostate cancer. The product is the first AI-enabled pathology product to gain marketing authorization. This was further followed by the collaboration of F. Hoffmann-La Roche Ltd. with Ibex in October 2021 for the development of artificial intelligence-based pathology applications for the improvement of patient care.

Furthermore, major players are adopting strategies, such as collaborations and partnerships with a focus on technological advancements, such as robotic light microscopy, digital imaging, multiple fiberoptic communications, and computerization, to enhance the adoption of digital pathology.

For instance, in December 2022, Deciphex launched Patholytix 3.0, a Digital Research Pathology Platform with an aim to revolutionize tools available for research pathologists and designed to overcome the limits of LIMS software that allows users to effectively manage associated data and samples. Furthermore, with the launch, the company also highlighted features of the new platform that impact workflow and offer simpler and more expedient report creation.

Companies Mentioned

• Leica Biosystems Nussloch GmbH (Danaher)
• Hamamatsu Photonics, Inc.
• Koninklijke Philips N.V.
• Olympus Corporation
• F. Hoffmann-La Roche Ltd
• Mikroscan Technologies, Inc.
• Inspirata, Inc.
• Epredia (3DHISTECH Ltd.)
• Visiopharm A/S
• Huron Technologies International Inc.
• ContextVision AB

Digital Pathology Market Report Highlights

• In 2022, the device segment held the largest share owing to the increased use of devices in academic research
• The disease diagnosis segment is anticipated to grow at the fastest growth rate over the forecast period due to an increasing prevalence of chronic diseases and demand for noble diagnosis techniques
• In 2022, the hospitals segment accounted for the largest revenue share due to the high incorporation of digital pathologies in healthcare settings for efficient disease diagnosis
• North America dominated the market due to the presence of well-established digital infrastructure and a number of technological advancements pertaining to the incorporation of technology in healthcare settings

Key Attributes:

Report Attribute	Details
No. of Pages	150
Forecast Period	2022 - 2030
Estimated Market Value (USD) in 2022	$975.5 Million
Forecasted Market Value (USD) by 2030	$1730 Million
Compound Annual Growth Rate	7.7%
Regions Covered	Global

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Digital Pathology Market Variables, Trends, & Scope

3.1 Market Lineage Outlook

3.1.1 Parent market

3.2 Market Dynamics

3.2.1 Market drivers analysis

3.2.2 Market restraint analysis

3.3 Penetration & Growth Prospect Mapping

3.4 Digital Pathology: Market Analysis Tools

3.4.1 Industry analysis - Porter's

3.4.2 PESTLE analysis

3.5 Regulatory Framework

Chapter 4 Digital Pathology Market Segment Analysis, By Product, 2016 - 2030 (USD Million)

Chapter 5 Digital Pathology Market Segment Analysis, By Application, 2016 - 2030 (USD Million)

Chapter 6 Digital Pathology Market Segment Analysis, By End-use, 2016 - 2030 (USD Million)

Chapter 7 Digital Pathology Market Segment Analysis, By Region, 2016 - 2030 (USD Million)

Chapter 8 Digital Pathology Market - Competitive Analysis

8.1 Recent Developments & Impact Analysis, by Key Market Participants

8.2 Company Categorization

8.3 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/f0oaol

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.